Home therapy aims to curb crime in young adults with mental illness
NCT ID NCT02922335
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This trial tests a therapy called Multisystemic Therapy for Emerging Adults (MST-EA) for young people aged 16–26 who have a mental illness and a recent arrest or jail release. The therapy is home-based and involves therapists and coaches working with the young adult and their family to reduce antisocial behavior and improve life skills. The study compares MST-EA to standard services to see if it lowers criminal charges and boosts self-efficacy and goal-setting over 16 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Multisystemic Therapy for Emerging Adults (MST-EA)
- What this could lead to
- If effective, MST-EA could provide a proven, home-based treatment to reduce serious antisocial behavior and criminal involvement in young adults with mental illness.
- What could go wrong
- This is a single effectiveness trial with 193 participants, so results may not apply broadly. The therapy is intensive and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTISOCIAL BEHAVIOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
North American Family Institute
Hamden, Connecticut, 06518, United States
-
North American Family Institute
Hartford, Connecticut, 06114, United States
-
North American Family Institute
New Haven, Connecticut, 06510, United States
-
Youth Villages
Johnson City, Tennessee, 37601, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.